Literature DB >> 3276726

Growth factors and the regulation of bone remodeling.

E Canalis1, T McCarthy, M Centrella.   

Abstract

Mesh：

Substances：

Year:  1988        PMID： 3276726      PMCID： PMC329568          DOI： 10.1172/JCI113318

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  34 in total

Review 1.  Transforming growth factors. Isolation, characterization, and interaction with cellular receptors.

Authors:  J Massagué
Journal:  Prog Med Virol       Date:  1985

2.  Purification and partial sequence of human osteoclast-activating factor: identity with interleukin 1 beta.

Authors:  F E Dewhirst; P P Stashenko; J E Mole; T Tsurumachi
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

3.  Platelet-derived growth factor. Structure, function, and roles in normal and transformed cells.

Authors:  T F Deuel; J S Huang
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

4.  Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin.

Authors:  D Pennica; G E Nedwin; J S Hayflick; P H Seeburg; R Derynck; M A Palladino; W J Kohr; B B Aggarwal; D V Goeddel
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

5.  Macrophage-derived growth factor for osteoblast-like cells and chondrocytes.

Authors:  L Rifas; V Shen; K Mitchell; W A Peck
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

6.  Effect of insulinlike growth factor I on DNA and protein synthesis in cultured rat calvaria.

Authors:  E Canalis
Journal:  J Clin Invest       Date:  1980-10       Impact factor: 14.808

7.  Multiple forms of endothelial cell growth factor. Rapid isolation and biological and chemical characterization.

Authors:  W H Burgess; T Mehlman; R Friesel; W V Johnson; T Maciag
Journal:  J Biol Chem       Date:  1985-09-25       Impact factor: 5.157

Review 8.  Interleukin-1.

Authors:  C A Dinarello
Journal:  Rev Infect Dis       Date:  1984 Jan-Feb

9.  Human tumor necrosis factor. Production, purification, and characterization.

Authors:  B B Aggarwal; W J Kohr; P E Hass; B Moffat; S A Spencer; W J Henzel; T S Bringman; G E Nedwin; D V Goeddel; R N Harkins
Journal:  J Biol Chem       Date:  1985-02-25       Impact factor: 5.157

10.  Osteoblasts mediate interleukin 1 stimulation of bone resorption by rat osteoclasts.

Authors:  B M Thomson; J Saklatvala; T J Chambers
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307
View more
  79 in total

Review 1.  Growth regulatory factors and bone.

Authors:  G R Mundy; D Chen; M Zhao; S Dallas; C Xu; S Harris
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

2.  Endogenous sex steroid, GH and IGF-I levels in normal elderly men: relationships with bone mineral density and markers of bone turnover.

Authors:  A Gürlek; O Gedik
Journal:  J Endocrinol Invest       Date:  2001-06       Impact factor: 4.256

3.  Biodegradable drug delivery system for the treatment of bone infection and repair.

Authors:  L Di Silvio; W Bonfield
Journal:  J Mater Sci Mater Med       Date:  1999 Oct-Nov       Impact factor: 3.896

4.  Circadian rhythm in type I collagen formation in postmenopausal women with and without osteopenia.

Authors:  B J Pedersen; A Schlemmer; C Rosenquist; C Hassager; C Christiansen
Journal:  Osteoporos Int       Date:  1995       Impact factor: 4.507

5.  Inflammatory cytokines induce synthesis and secretion of gro protein and a neutrophil chemotactic factor but not beta 2-microglobulin in human synovial cells and fibroblasts.

Authors:  E E Golds; P Mason; P Nyirkos
Journal:  Biochem J       Date:  1989-04-15       Impact factor: 3.857

6.  Impaired bone formation in male idiopathic osteoporosis: further reduction in the presence of concomitant hypercalciuria.

Authors:  J E Zerwekh; K Sakhaee; N A Breslau; F Gottschalk; C Y Pak
Journal:  Osteoporos Int       Date:  1992-05       Impact factor: 4.507

7.  Activin A suppresses osteoblast mineralization capacity by altering extracellular matrix (ECM) composition and impairing matrix vesicle (MV) production.

Authors:  Rodrigo D A M Alves; Marco Eijken; Karel Bezstarosti; Jeroen A A Demmers; Johannes P T M van Leeuwen
Journal:  Mol Cell Proteomics       Date:  2013-06-17       Impact factor: 5.911

Review 8.  The botanical molecule p-hydroxycinnamic acid as a new osteogenic agent: insight into the treatment of cancer bone metastases.

Authors:  Masayoshi Yamaguchi
Journal:  Mol Cell Biochem       Date:  2016-08-30       Impact factor: 3.396

9.  Activin-A binding and biochemical effects in osteoblast-enriched cultures from fetal-rat parietal bone.

Authors:  M Centrella; T L McCarthy; E Canalis
Journal:  Mol Cell Biol       Date:  1991-01       Impact factor: 4.272

10.  Effects of estrogen replacement on insulin-like growth factor I concentrations in serum and bone tissue and on interleukin 1 secretion from spleen macrophages in oophorectomized rats.

Authors:  F Sato; Y Ouchi; A Masuyama; T Nakamura; T Hosoi; Y Okamoto; N Sasaki; M Shiraki; H Orimo
Journal:  Calcif Tissue Int       Date:  1993-08       Impact factor: 4.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.